Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Activation of NMDARs can both promote neuronal health and kill neurons. In this Review, Hardingham and Bading discuss the downstream effects of stimulation of synaptic NMDARs and extrasynaptic NMDARs that result in promotion of neuroprotection and cell death, respectively.
Glucocorticoid hormones modulate the acquisition and consolidation of memories of stressful events. Krugers and colleagues review recent evidence that glucocorticoids achieve this through rapid and persistent effects on AMPA receptors by activation of mineralocorticoid receptors and glucocorticoid receptors, respectively.
Emotional stimuli, such as a fear-expressing face, can be processed without being consciously perceived and can influence behaviour. Tamietto and de Gelder describe the subcortical pathway that processes such stimuli, and discuss whether subcortical versus cortical processing of stimuli translate into non-conscious versus conscious perception. An interview with Beatrice de Gelder for Neuropod is available for download.
tau regulates the interaction of postsynaptic density protein 95 (PSD95) with NMDA (N-methyl-D-aspartate) receptors, which are thought to mediate Aβ toxicity.
Socioeconomic status (SES) influences brain development. Farah and colleagues discuss evidence that prenatal factors, parent–child interactions and cognitive stimulation mediate this effect, and consider implications for alleviating SES-related disparities in mental health and academic achievement.
Reliable propagation of spiking activity in the brain is vital for information processing. Kumar, Rotter and Aertsen now propose that under certain conditions asynchronous and synchronous propagation of spiking activity can co-exist in a modular neuronal network, and they suggest experimental strategies to test this hypothesis.
In this Perspective, Vollenweider and Kometer discuss the clinical potential of psychedelic drugs for the treatment of various psychiatric disorders, and describe the molecular mechanisms by which classical hallucinogens and dissociative anaesthetics affect serotonin and glutamate systems. An interview with Franz X. Vollenweider for Neuropod is available for download.